| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=10uM, Vamifeport, Ferroportin inhibitor targeting SLC40A1 (Novartis, 129052159) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/129052159 |
| Similar Terms | |
| Downloads & Tools |
5 genes differentially expressed following the BE-90-IY33_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| RPL37 | ribosomal protein L37 | 0.617133 |
| MYL12B | myosin, light chain 12B, regulatory | 0.470916 |
| PRDM8 | PR domain containing 8 | 0.424823 |
| GPX4 | glutathione peroxidase 4 | 0.281856 |
| Symbol | Name | Standardized Value |
|---|---|---|
| TMEM50A | transmembrane protein 50A | -0.214404 |